Document Classification

Section Type: RESULTS

Text: At 12 months, seroprotection rates were higher in revaccinated patients vs controls (measles, 100 % vs 92 % [95 % CI, 84 % -99 %] ; mumps, 97 % [95 % CI, 95 % -100 %] vs 81 % [95 % CI, 72 % -93 %] ; and rubella, 100 % vs 94 % [95 % CI, 86 % -100 %], respectively), as were antibody concentrations against measles (1. 63 vs 0. 78 IU/mL ; P =. 03), mumps (168 vs 104 RU/mL ; P =. 03), and rubella (69 vs 45 IU/mL ; P =. 01).